Jeffrey W. Sherman

2012

In 2012, Jeffrey W. Sherman earned a total compensation of $989.9K as Executive Vice President, Development, Manufacturing and Regulatory Affairs, and Chief Medical Officer at Horizon Pharma, a 11% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$142,000
Salary$384,800
Stock Awards$462,000
Other$1,070
Total$989,870

Sherman received $462K in stock awards, accounting for 47% of the total pay in 2012.

Sherman also received $142K in non-equity incentive plan, $384.8K in salary and $1.1K in other compensation.

Rankings

In 2012, Jeffrey W. Sherman's compensation ranked 6,168th out of 11,487 executives tracked by ExecPay. In other words, Sherman earned more than 46.3% of executives.

ClassificationRankingPercentile
All
6,168
out of 11,487
46th
Division
Manufacturing
2,194
out of 4,253
48th
Major group
Chemicals And Allied Products
551
out of 1,198
54th
Industry group
Drugs
375
out of 920
59th
Industry
Pharmaceutical Preparations
296
out of 700
58th
Source: SEC filing on June 2, 2014.

Sherman's colleagues

We found four more compensation records of executives who worked with Jeffrey W. Sherman at Horizon Pharma in 2012.

2012

Timothy Walbert

Horizon Pharma

Chief Executive Officer

2012

Robert De Vaere

Horizon Pharma

Chief Financial Officer

2012

Todd Smith

Horizon Pharma

Executive Vice President and Chief Commercial Officer

2012

Michael Adatto

Horizon Pharma

Former Senior Vice President, Managed Care and Commercial Development

You may also like